13 results on '"Lu, C. -H"'
Search Results
2. 101P Real-world prevalence of MSI-H/dMMR across 6 different tumor types in Asia
3. 1020MO AdvanTIG-203: Phase II randomized, multicenter study of ociperlimab (OCI) + tislelizumab (TIS) in patients (pts) with unresectable, locally advanced, recurrent/metastatic esophageal squamous cell carcinoma (ESCC) and programmed cell death-ligand 1 (PD-L1) positivity
4. The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979–2003)
5. A phase Ia/Ib trial of tislelizumab, an anti-PD-1 antibody (ab), in patients (pts) with advanced solid tumors
6. Incidence, risk factors, and outcomes of arterial thromboembolism in patients with pancreatic cancer following palliative chemotherapy
7. Venous thromboembolism in Asian patients with pancreatic cancer who underwent palliative chemotherapy: Low prevalence, but a poor prognostic factor for early onset
8. 362PD Development and validation of a nomogram to predict the probability of recurrence in patients with major salivary gland cancers
9. 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan
10. 70O - A phase Ia/Ib trial of tislelizumab, an anti-PD-1 antibody (ab), in patients (pts) with advanced solid tumors
11. 323P Complementary role of the MSKCC nomogram to the AJCC system for the prediction of relapse of major salivary gland carcinoma after surgery
12. 199P - Incidence, risk factors, and outcomes of arterial thromboembolism in patients with pancreatic cancer following palliative chemotherapy
13. 753P - Venous thromboembolism in Asian patients with pancreatic cancer who underwent palliative chemotherapy: Low prevalence, but a poor prognostic factor for early onset
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.